Abstract
True allergic reactions are IgE-mediated immune reactions and are also termed type I reactions, where the spectrum of presentation may range from urticaria to severe anaphylactic shock. Currently, 3% of the patients who use sulfonamide antibiotics develop an allergic reaction, with the most common being the development of a maculopapular rash. Sulfonamides are chemical compounds that can be further divided into 3 groups based on differences in their structural makeup. Several cases reviewing the cross-reactivity between sulfonamide antibiotics and nonantibiotics have suggested an increased risk of cross-reactivity and therefore recommend other treatment strategies to avoid a possible anaphylactic reaction; however, other reports argue that patients with a history of sulfonamide allergy who received sulfonamide nonantibiotics did not experience any adverse reactions. Pertinent data extracted from these studies are reviewed and evaluated.
Get full access to this article
View all access options for this article.
